Understanding suicidal intent in drug overdose deaths
Official title: Suicidal intent in fatal drug overdoses
Funded at Northwestern University at Chicago · NIH-10880425 · Data updated 2026-11-12
This study looks at how we can tell the difference between accidental and intentional drug overdoses by examining various reports and data, and it's aimed at helping people understand the reasons behind these tragic deaths in areas where drug use is a big problem.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project start | July 1, 2023 |
| Project end | December 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $240,000 |
| NIH project number | 5R21DA059189-02 |
| Project ID | NIH-10880425 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who have experienced substance use issues or suicidal ideation, particularly in regions with high drug overdose rates.
✕Less likely to help
Patients who have not experienced substance use or suicidal thoughts may not benefit directly from this research.
What this research studies
This research investigates the classification of intent in fatal drug overdoses, particularly distinguishing between accidental and suicidal deaths. By analyzing data from death certificates, toxicology reports, and coroner investigations, the study aims to identify factors that influence how these deaths are classified. The research employs a mixed methods approach, combining quantitative data analysis with linguistic analysis to better understand the complexities surrounding drug overdose fatalities. The focus is on a specific region with high rates of drug abuse, utilizing national databases to gather comprehensive insights.
Why it matters
Potential benefit: If successful, this research could lead to more accurate classifications of drug overdose deaths, potentially improving mental health interventions and support for at-risk populations.
How similar studies have gone: Previous research has indicated that understanding the nuances of intent in drug-related fatalities can lead to improved public health strategies, suggesting that this approach has potential for success.
Where this research is happening
-
Northwestern University at Chicago
Chicago, United States Active
Researchers
- Principal investigator: Lundberg, Alexander — Northwestern University at Chicago
- Study coordinator: Lundberg, Alexander
Related research
Other NIH-funded projects on the same topics.
-
High-intensity exercise as a treatment for Parkinson's disease
This study is looking at whether doing high-intensity endurance exercise can help people who have just been diagnosed with Parkinson's disease feel better and slow down their symptoms, especially since current medications don't always do the trick.
-
Software to quickly assess organ dose after radionuclide exposure
This study is creating a helpful software tool that quickly calculates how much radiation your organs absorb after you've taken certain radioactive substances, so you can get better care and treatment based on your individual needs.
-
Investigating innovative approaches to improve health outcomes.
This study is looking for better ways to improve your care and treatment, so you can get more personalized options that work best for you.
-
Investigating innovative approaches to improve health outcomes.
This study is looking for new ways to improve care and treatment for patients, and if you join, you might help test some exciting new methods that could lead to better health for everyone.
-
Investigating innovative approaches to improve health outcomes.
This study is looking for ways to improve care and treatment for patients like you, by trying out new methods that could help manage your health better.
-
Investigating core biological processes
This study is all about exploring important biological processes that affect our health, and it invites patients to help discover new ways to improve care for everyone.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.